In this issue:
MAIT cell depletion in HCV-induced liver inflammation
Antiviral therapy in CSPH
Assessing the risk of HCC after IFN-free therapy
HEV linked to neuralgic amyotrophy
Stopping TDF in noncirrhotic HBeAg– patients
Risk of HCC after HBsAg seroclearance
Increasing liver cancer burden in an HBV-endemic population
Risk factors for HCC beyond 5 years of ETV or TDF
Target MSL2 in the treatment of HBV-related HCC?
CREBH regulates TGF-β transcription in HCV-infected cells
Please login below to download this issue (PDF)